Report Description
United States Contraceptives Devices Market Outlook 2031:
The United States contraceptives devices market size was valued at USD 4.56 Billion in 2022 and is projected to reach USD 7.66 Billion by 2031, expanding at a CAGR of 5.93% during the forecast period 2023 - 2031. The growth of the market is attributed to the reduced unplanned pregnancies and their consequences.
Contraceptives device aids in preventing pregnancy by using drugs or devices. It is also known as birth control and fertility control devices. Increasing use of contraceptives at home has improved health related outcomes. Robust government promotions and schemes for women and child health is driving the market growth.
These devices are used to prevent transfer of sexually transmitted diseases or infections. Contraceptive devices could be temporary or permanent and are available for both men as well as women. Condoms are most preferred contraceptive devices and hold a large market share in the world. Copper IUD is basically used by the women to avoid possible side effects.
Bayer HealthCare collaborated with 11 NGOs, which in turn, led to increase of its share in the contraceptives devices market. Every year on September 26, “World Contraception Day” is celebrated to increase awareness about contraceptive methods, and encourage young people to make right decision about their reproductive health.
Contraceptives Devices Market Trends, Drivers, Restraints, and Opportunities
- Increasing population is anticipated to drive the market growth during the forecast period.
- Rising use of contraception in young women is projected to boost the market growth in the coming years.
- Growing requirement for family planning is expected to spur the market growth during the forecast period.
- Increasing awareness of modern contraception is anticipated to drive the market growth during the forecast period.
- Rising higher educational attainment is anticipated to drive the market growth during the forecast period.
- Growing health issues associated with teenage pregnancies is projected to boost the market growth in the coming years.
- Rising use of oral pills to avoid unplanned pregnancy is projected to boost the market growth in the coming years.
- Lack of social acceptance is estimated to restrict the market growth.
- Increasing health risks by using contraceptive devices can restrain the market growth in the coming years.
- Availability of alternate contraceptive methods is estimated to restrict the market growth.
- Growing number of clinics in the contraceptive market can estimate the market growth.
- Increasing medical tourism in emerging nations is anticipated to create significant opportunities for the market players.
Scope of the Contraceptives Devices Market Report
The report on the United States contraceptives devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
United States Contraceptives Devices Market- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016–2021
|
Forecast Period
|
2023–2031
|
Segmentation
|
Types (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Device (IUD), and Others) and Gender (Mal, and Female)
|
Country Scope
|
The US
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Bayer Healthcare; Abbvie (Allergan PLC); Reckitt Benckiser Group plc; Cooper Surgical, Inc.; and Pregna International Limited
|
United States Contraceptives Devices Market Segment Insights
Cervical caps segment to hold a significant market share
Based on types, the Unites States contraceptives devices market is divided into condoms, diaphragms, cervical caps, sponges, vaginal rings, intra uterine device (IUD), and others.
The diaphragms segment is anticipated to hold a key share of the market in the coming years due to portability and reusability. However, the caps segment is anticipated to expand at a rapid pace during the forecast period, as it keeps sperm from entering the uterus and fallopian tubes.
Female segment is anticipated to hold a large market share
On the basis of gender, the United States contraceptives devices market is segmented into male and female. The male segment is projected to constitute a major market share during the forecast period due to its cost-effectiveness than female contraceptive devices.
On the other hand, the female segment is anticipated to expand at a rapid pace during the forecast period owing to reducef risk of uterine cancer, and regulates menstrual cycles and makes periods less painful.

Segments
The United States contraceptives devices market has been segmented on the basis
Types
- Condoms
- Diaphragms
- Cervical Caps
- Sponges
- Vaginal Rings
- Intra Uterine Device (IUD)
- Others
Genders
Country
Key Players
Competitive Landscape
Key players competing in the United States contraceptives devices market includes Bayer Healthcare; Abbvie (Allergan PLC); Reckitt Benckiser Group plc; Cooper Surgical, Inc.; and Pregna International Limited.
Some of these players are engaging in business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market share.
In India, Durex a Britain brand introduced a new product range, ‘‘Durex invisible condoms’’ in October 2020 as India’s thinnest product.

Table Of Content
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Contraceptives Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Contraceptives Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Contraceptives Devices Market - Supply Chain
4.5. Global Contraceptives Devices Market Forecast
4.5.1. Contraceptives Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Contraceptives Devices Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Contraceptives Devices Market Absolute $ Opportunity
5. Global Contraceptives Devices Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Contraceptives Devices Market Size and Volume Forecast by Types
5.3.1. Condoms
5.3.2.
Diaphragms
5.3.3.
Cervical Caps
5.3.4.
Sponges
5.3.5.
Vaginal Rings
5.3.6.
Intra Uterine Device (IUD)
5.3.7.
Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Contraceptives Devices Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Contraceptives Devices Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Contraceptives Devices Demand Share Forecast, 2019-2026
7. North America Contraceptives Devices Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Contraceptives Devices Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Contraceptives Devices Market Size and Volume Forecast by Types
7.4.1. Condoms
7.4.2.
Diaphragms
7.4.3.
Cervical Caps
7.4.4.
Sponges
7.4.5.
Vaginal Rings
7.4.6.
Intra Uterine Device (IUD)
7.4.7.
Others
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Contraceptives Devices Demand Share Forecast, 2019-2026
8. Latin America Contraceptives Devices Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Contraceptives Devices Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Contraceptives Devices Market Size and Volume Forecast by Types
8.4.1. Condoms
8.4.2.
Diaphragms
8.4.3.
Cervical Caps
8.4.4.
Sponges
8.4.5.
Vaginal Rings
8.4.6.
Intra Uterine Device (IUD)
8.4.7.
Others
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Contraceptives Devices Demand Share Forecast, 2019-2026
9. Europe Contraceptives Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Contraceptives Devices Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Contraceptives Devices Market Size and Volume Forecast by Types
9.4.1. Condoms
9.4.2.
Diaphragms
9.4.3.
Cervical Caps
9.4.4.
Sponges
9.4.5.
Vaginal Rings
9.4.6.
Intra Uterine Device (IUD)
9.4.7.
Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Contraceptives Devices Demand Share Forecast, 2019-2026
10. Asia Pacific Contraceptives Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Contraceptives Devices Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Contraceptives Devices Market Size and Volume Forecast by Types
10.4.1. Condoms
10.4.2.
Diaphragms
10.4.3.
Cervical Caps
10.4.4.
Sponges
10.4.5.
Vaginal Rings
10.4.6.
Intra Uterine Device (IUD)
10.4.7.
Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Contraceptives Devices Demand Share Forecast, 2019-2026
11. Middle East & Africa Contraceptives Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Contraceptives Devices Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Contraceptives Devices Market Size and Volume Forecast by Types
11.4.1. Condoms
11.4.2.
Diaphragms
11.4.3.
Cervical Caps
11.4.4.
Sponges
11.4.5.
Vaginal Rings
11.4.6.
Intra Uterine Device (IUD)
11.4.7.
Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Contraceptives Devices Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Contraceptives Devices Market: Market Share Analysis
12.2. Contraceptives Devices Distributors and Customers
12.3. Contraceptives Devices Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Bayer Healthcare
12.4.2.
Abbvie (Allergan PLC)
12.4.3.
Reckitt Benckiser Group plc
12.4.4.
Cooper Surgical, Inc.
12.4.5.
Pregna International Limited